ZUG, CH / JANUARY 9, 2019 - FOR IMMEDIATE RELEASE: Global Markets Intelligence ("GMI") today announced an independent, private investigation into the malicious actions against the shareholders of targeted cannabis companies.
A spokesperson for GMI, in a brief statement said: "....the importance to uncover such malicious acts against shareholders is paramount to the credibility and survival of a legalized industry. Investors of both private and public companies, from retails outlets to medical cannabis operators, should remain vigilant when faced with immediate, untested allegations of wrongdoing".
Further, the spokesperson focused on an instance of precisely this scenario, that continues to play out in the Canadian marketplace, starting with a company called CEN Biotech Inc in mid 2014. Since that time, the same scenario continues against other unsuspecting companies and shareholders resulting in millions of dollars in losses.
While the spokesperson for GMI didn't confirm or deny an investigation into specific companies and how they were targeted, the indication was that all eyes and focus are on protecting shareholders and companies from deliberate malicious acts, wrapped in claims of 'free speech' purely meant to harm economic interests of innocent parties.
GMI wishes to also make shareholders aware that usually, in cases such as these, there is a complex, and premeditated plan well before any unsuspecting company or shareholder realizes it. The shock usually results in company(s) and shareholder(s) directing blame towards each other, while the perpetrators walk away having served their personal agenda.
GMI believes they have enough evidence in two such cases to bring the matters forward.
Updates regarding any matters brought before the Courts of competent jurisdiction, and not subject to any publication bans will be posted here once they are entered into the public record.